HCID 86733872, compound → HCID 22792300, compound
Reaction equation
[CH3:1][O:2][C:3](=[O:32])[C@H:4]([CH2:25][C:26]1[CH2:27][CH:28]=[CH:29][CH2:30][CH:31]=1)[NH:5][C:6](=[O:24])[C@H:7]([CH:16](C(C)(C)C)[C:17](=[O:19])[OH:18])[NH:8]C(OC(C)(C)C)=O>FC(F)(F)C(O)=O>[CH3:1][O:2][C:3](=[O:32])[C@H:4]([CH2:25][C:26]1[CH2:27][CH:28]=[CH:29][CH2:30][CH:31]=1)[NH:5][C:6](=[O:24])[C@H:7]([CH2:16][C:17](=[O:18])[OH:19])[NH2:8]Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
β-tert.-butyl-Nα-tert.-butyloxycarbonyl-L-aspartyl-2,5-dihydro-L-phenylalanine methyl ester (13 g.) is dissolved in trifluoroacetic acid (80 ml.) and the solution kept under nitrogen for one hour. The solvent is concentrated in vacuo and the residue is triturated with ether-hexane until it becomes solid. This material is dissolved in water (ca 30 ml.) neutralized with DEAE sephadex (OH cycle), filtered and the filtrate concentrated in vacuo to a small, volume (ca 5 ml.). The dipeptide ester is crystallized on standing in the refrigerator.
Workup
- concentrationThe solvent is concentrated in vacuo
- customthe residue is triturated with ether-hexane until it
- dissolutionThis material is dissolved in water (ca 30 ml.)
- filtrationfiltered
- concentrationthe filtrate concentrated in vacuo to a small, volume (ca 5 ml.)
- customThe dipeptide ester is crystallized
Sources & evidence
- ORD record
- ord-0740d40399e544deaa2d1f95ac5c9e05
- Source dataset
- uspto-grants-1976_08
- Patent number
- US03978034
Reaction notes
Loading…